Second-line antidiabetic drugs: friend or foe of the liver.

J Liver Cancer · 2025 · PMC12518991 · PMID 40567201

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

showed a trendno p-value reported

28 , GLP-1 RAs showed a trend toward lower overall mortality compared to DPP-4i users, though this did not reach statistical significance (aHR, 0.89; 95% CI, 0.81-0.98). 28 , although no significant benefit was seen in those with cirrhosis (cohort 2).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.